Related Experiment Video
Updated: Jun 1, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Arterial stiffness: from physiology to clinical implications
Alberto Milan1, Francesco Tosello, Ambra Fabbri
1Department of Medicine and Experimental Oncology, Internal Medicine, Hypertension Unit, University of Turin, Turin, Italy. alberto.milan@unito.it
Insights
Arterial stiffness, measured by pulse wave velocity (PWV), is a key indicator of hypertension-related organ damage. While some drugs effectively manage central hemodynamics, their impact on PWV requires further investigation.
Area of Science:
- Cardiology
- Vascular Medicine
- Hypertension Management
Background:
- Arterial stiffness, assessed by pulse wave velocity (PWV), is recognized in European guidelines as an index of hypertension-related cardiovascular target organ damage.
- Increased arterial stiffness impacts aortic hemodynamics, raising cardiac afterload and reducing coronary perfusion.
- PWV is an independent predictor of cardiovascular events and mortality across diverse patient populations.
Purpose of the Study:
- To review the role of PWV in assessing cardiovascular risk in hypertension.
- To evaluate the efficacy of various therapeutic strategies in managing arterial stiffness.
- To compare the effects of different drug classes on central hemodynamics and PWV.
Main Methods:
- Literature review of studies on arterial stiffness, PWV, and hypertension management.
- Analysis of clinical trial data and observational studies.
- Comparison of drug classes targeting the renin-angiotensin-aldosterone system, calcium-channel blockers, and beta-blockers.
Main Results:
- Therapies for arterial hypertension are crucial for managing increased PWV.
- Drugs targeting the renin-angiotensin-aldosterone system and calcium-channel blockers show specific efficacy in controlling central hemodynamics.
- Comparative data on the direct effects of these drug classes on PWV are limited.
Conclusions:
- Arterial stiffness assessment via PWV is vital in hypertension management.
- While certain antihypertensives improve central hemodynamics, their differential impact on PWV needs further research.
- Additional studies are required to clarify the clinical and prognostic significance of drug-induced changes in arterial stiffness.
Abstract:
Current European guidelines for the management of arterial hypertension introduce the assessment of arterial stiffness by pulse wave velocity (PWV) as an index of hypertension-related cardiovascular target organ damage. An increase in arterial stiffness is related to haemodynamic modifications at the level of the aorta, leading to a rise in cardiac afterload, a reduction in coronary perfusion and an overstretch of the aortic walls. An increasing number of studies have demonstrated the accuracy of PWV as an independent predictor of cardiovascular events and cardiovascular mortality in patients with different co-morbidities and cardiovascular risk. Many strategies have demonstrated their efficacy in preventing arterial stiffening; therapy of arterial hypertension is the mainstay in the management of patients with increased PWV and altered pulse wave reflection. Literature has clearly shown the specific efficacy of drugs interfering with the renin-angiotensin-aldosterone system and calcium-channel blockers in the control of central haemodynamics, particularly when compared with β-blockers (β-adrenoceptor antagonists). The same action has not yet been demonstrated on PWV. Further studies are needed to assess the real relative efficacy of different drug classes on the management of arterial stiffness and the clinical and prognostic relevance of these therapies.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Hypertension II: Pathophysiology
Peripheral Artery Disease III: Interprofessional Care
